PharmaBoardroom

We know the raw data already in the Brazilian market and the number changes since our last visit in 2007 – but how would you interpret these…

Michael Sean Reilly: General Manager for Pharmaceuticals Juan Carlos Berbessi: Medical Director Maria del Pilar Rubio: Medical Manager for Vaccines…

The 2006 acquisition of Schering by Bayer is a prime example of the way that big pharma is now approaching growth through acquisition in this…

Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the…

You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and…

What has been the evolution of Roche’s operations in Colombia’s over the course of its proud 52-year history here? As with almost all…

Baxter Chile established itself in the country through the acquisition of a local manufacturer in 1995. What have been the main challenges for the…

As the CEO of Farmindustria since 1998, what would you say has been your recipe for the impressive success that the company has experienced,…

You were appointed general manager of Astellas Poland in early 2006, only a bit after Astellas Pharma Inc. was established, on April 1, 2005 through…

As Squibb Corporation and Bristol-Myers merged in 1989, Bristol-Myers Squibb has been officially operating in this market since that date, but the…

What have been Merck’s major milestones and achievements for its pharmaceutical division since you took the reins? I have been managing the…

As I was doing research on your company, GC-2, I was unable to find a lot of information since it is a rather new company. Could you bring me up to…